Objective: This study aims to understand the mechanisms underlying altered phosphorylation of myofilament proteins in heart failure.
I n animal hearts, elevated sympathetic activity stimulates the β-adrenergic signal to promote inotropy and lusitropy via the concerted protein kinase A (PKA) phosphorylation of substrates at multiple subcellular locations. PKA is spatially and temporally regulated through a set of A-kinase anchoring protein complexes. 1 As a result, the precise PKA phosphorylation of myofilament proteins, such as cardiac troponin I (TnI) and myosin-binding protein C, and Ca 2+ -handling proteins, such as phospholamban (PLB) and ryanodine receptor on the sarcoplasmic reticulum (SR), is necessary to co-ordinate positive inotropic and lusitropic cardiac effects. 2, 3 Chronic adrenergic signaling also promotes structural and functional remodeling in the myocardium, which contributes to cardiac hypertrophy and eventually heart failure in a variety of clinical conditions. A desensitized cardiac β adrenergic receptor (βAR) signaling pathway, 4 a hallmark of the failing heart, is associated with a reduced number of β 1 AR-but not β 2 AR-binding sites at the plasma membrane (PM). As a consequence, diminished βAR signaling may lead to lower PKA-mediated protein phosphorylation after adrenergic stimulation.
Here, we develop a novel genetically encoded PKA biosensor that is anchored on the myofibrils to probe PKA activity in cardiac myocytes from a rabbit hypertrophic heart failure model. 15 Our data show that although the β 1 AR-induced PKA signal is detected at the myofilaments, the sarcolemma, and the SR in healthy myocytes, the β 2 AR-induced PKA signal is restricted along the sarcolemma and the SR and does not have access to the myofilaments. However, in hypertrophic failing rabbit myocytes, stimulation of β 2 AR promotes a strong PKA activity at the myofilaments. The emerging β 2 AR signal is associated with downregulation of caveolin-3 in hypertrophic failing myocytes, a key structural protein of caveolae that confines the β 2 AR signal. 16 Thus, in failing myocytes, stimulation of the β 2 AR promotes strong PKA activity and PKA phosphorylation of TnI. Moreover, we demonstrate that reintroduction of caveolin-3 normalizes the distribution of the β-adrenergic signal and restores contractile response to adrenergic stimulation.
Methods Experimental Animals, Cardiac Myocyte Isolation, and Culture
The animal care and experimental protocols followed US National Institutes of Health guidelines and were approved by the Institutional Animal Care and Use Committees of the University of California at Davis. Heart failure (HF) was induced in New Zealand White rabbits by combined aortic insufficiency and stenosis as previously described. 15 
Fluorescence Resonance Energy Transfer Measurements
Images were acquired using a Leica DMI3000B inverted fluorescence microscope (Leica Biosystems, Buffalo Grove, IL) with a 40× oil-immersion objective lens and a charge-coupled device camera controlled by Metafluor software (Molecular Devices, Sunnyvale, CA). Fluorescence images for fluorescence resonance energy transfer (FRET) analysis were obtained as described previously. 17 
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6 software (La Jolla, CA).
Expanded methods can be found online (Online Data Supplement).
Results

Novel Biosensors Reveal Highly Localized β 2 ARInduced PKA Activity That Does not Reach the Myofilaments in Healthy Rabbit Cardiac Myocytes
To analyze the dynamics of PKA activity on the myofilaments, we took a novel strategy to anchor FRET-based A-kinase activity reporter 3 (AKAR3) 17 onto the myofilaments by linking AKAR3 to the C terminus of troponin T (myofilament-AKAR3; Figure 1A ). Myofilament-AKAR3 was used together with 2 other targeted PKA biosensors developed previously: PM-AKAR3 is linked to a PM-targeting sequence from Kras and SR-AKAR3 is linked to the transmembrane domain of PLB. 10, 18 Confocal analysis of rabbit adult cardiac myocytes shows that the biosensors display proper subcellular distribution, colocalizing with specific markers for subcellular organelles ( Figure 1B ). The introduction of biosensors does not affect adrenergic stimulation-induced PKA phosphorylation of endogenous TnI ( Figure 1C ) or PLB. 10, 18 These data indicate that the molecular pathways are preserved on the expression of biosensors, and the targeted probes are suitable for analysis of PKA activity in the microdomains of adult cardiac myocytes.
We further characterized the AKAR3 biosensors in response to a set of incremental doses of β-adrenergic agonist isoproterenol in adult rabbit myocytes. Stimulation of myocytes with isoproterenol induces dose-dependent increases in FRET ratio of the PM-, SR-, and myofilament-anchored AKAR3 biosensors, and the maximal responses are higher at the PM than those at the SR and myofilament ( Figure  1D ; Online Figure I ). The responses of PM-AKAR3 are also more sensitive to isoproterenol stimulation than those of SR-AKAR3 and myofilament-AKAR3 (Figure 1D and 1E; Online Figure I ). These data are consistent with previous studies showing that PKA phosphorylation of substrates at the PM is more sensitive to lower doses of isoproterenol stimulation than those at the intracellular compartments. 19 The isoproterenolinduced maximal responses are not because of saturation of individual biosensors because cotreatment of myocytes with forskolin and IBMX (3-isobutyl-1-methylxanthine) induces higher increases in FRET ratios of biosensors than those induced by isoproterenol, respectively ( Figure 1F) . Notably, the isoproterenol-induced maximal responses in these localized biosensors are equivalent when normalized by those induced by cotreatment of forskolin and IBMX ( Figure 1G ), suggesting that these biosensors are functionally comparable in response to adrenergic stimulation in rabbit myocytes.
To analyze the alteration of local PKA dynamics at the myofilaments in failing heart, we used cardiac myocytes isolated from rabbits with hypertrophic HF induced by combined aortic insufficiency and stenosis. 15 Myocytes from age-matched rabbits with sham surgery (SHAM) were used as controls. In age-matched SHAM myocytes, stimulation of the βAR with a saturated dose of isoproterenol (100 nmol/L) leads to an increase of PKA activity, which is completely blocked by β 1 AR selective antagonist CGP20712A but not by β 2 AR selective antagonist ICI118551 (Figure 2A) . Accordingly, stimulation of SHAM myocytes with isoproterenol significantly promotes PKA phosphorylation of TnI at serine 23/24, which is also blocked by CGP20712A but not by ICI118551 ( Figure 2B ). However, stimulation with isoproterenol promotes a stronger PKA activity associated with the myofilaments in failing myocytes than SHAM cells ( Figure 2C and 2D) . Notably, stimulation of the β 2 AR also induces a strong increase in PKA activity in failing myocytes ( Figure 2C and 2D) . Consistent with the FRET measurement of PKA activity, stimulation of the β 2 AR promotes a strong increase in PKA phosphorylation of TnI in HF myocytes but not in SHAM controls ( Figure 2E ). These data indicate that in HF myocytes, the β 2 AR gains an ability to promote a strong PKA signal on the myofilaments.
βAR-Induced PKA Activity Is Diminished at the SR and the PM in Failing Rabbit Myocytes
We also examined the alteration of local PKA dynamics at the SR in failing myocytes, an important intracellular organelle that regulates calcium signaling for myocyte contraction. In SHAM myocytes, stimulation of the βAR promotes a significant increase in PKA activity at the SR, which is inhibited by β 1 AR antagonist CGP20712A but not by β 2 AR antagonist ICI118551 ( Figure 3A) . Consistent with the FRET-based measurement of PKA activity, stimulation of SHAM myocytes with isoproterenol promotes PKA phosphorylation of PLB at serine 16, which is completely blocked by CGP20712A but not by ICI118551 ( Figure 3B ). However, stimulation with isoproterenol promotes a weaker PKA activity at the SR in failing myocytes than that in SHAM cells ( Figure 3C and 3D) . Further analysis reveals that the β 1 AR-induced PKA activity at the SR is reduced, whereas the β 2 AR-induced PKA activity at the SR is slightly increased (Figure 3C and 3D) . Consistently, the adrenergic-induced PKA phosphorylation of PLB is diminished in HF myocytes compared with those in SHAM controls. In both SHAM and HF cells, the β 1 AR acts as the primary receptor subtype in adrenergic stimulation ( Figure 3E ). These data indicate that in HF myocytes, the βAR-induced PKA activity is diminished at the SR for substrate phosphorylation.
In comparison, stimulation of βAR promotes a robust increase in PKA activity at the PM in SHAM myocytes, which is significantly decreased in HF myocytes ( Figure 4A through 4C). Inhibition of either β 1 AR with CGP20712A or β 2 AR with ICI118551 attenuates PKA activity induced by isoproterenol, with a stronger inhibition by the β 1 AR blocker CGP20712A ( Figure 4B ). Further analysis reveals that the reduced adrenergic response at the PM in HF myocytes is primarily because of a diminished β 1 AR-stimulated PKA activity ( Figure 4A and 4D). These data suggest that the βAR-induced PKA activity is diminished at the PM in failing myocytes.
Redistribution of Phosphodiesterase Activity Contributes to Elevated PKA Activity on the Myofilaments in Failing Heart
Recent studies have also revealed essential roles of alteration in phosphodiesterase (PDE) expression in remodeling of adrenergic signal in HF myocytes. 11, 20 We next studied the involvement of various cAMP PDEs on the modification of local PKA activity in HF myocytes. In SHAM myocytes, inhibition of PDE3 with cilostamide induces a strong increase in PKA activity at the myofilaments and the SR but not at the PM ( Figure 5A through 5C). In comparison, inhibition of PDE4 with rolipram induces a strong response in PKA activity at the PM and, to a lesser extent, at the myofilaments and the SR ( Figure 5D through 5F). Consistent with these observations, PDE3 displays colocalization with the myofilament-binding protein actin, whereas both PDE4D and PDE4B display colocalization with the PM marker caveolin-3 (Online Figure II) . In HF myocytes, the myofilament-associated PDE3 activity is decreased ( Figure 5A and 5G), whereas the PM-associated PDE3 activity is increased relative to SHAM controls ( Figure 5C and 5I), suggesting a shifted distribution of PDE3 activity from the myofilaments to the sarcolemma. In comparison, the PM-associated PDE4 activity in HF myocytes is decreased relative to SHAM controls ( Figure 5F and 5I). Meanwhile, inhibition of PDE4 induces a small increase in PKA activity at the SR in SHAM myocytes, which is enhanced in HF cells ( Figure 5E and 5H). However, the SR-associated PDE3 activity is not significantly altered in HF cells ( Figure 5B and 5H). In addition, inhibition of PDE2 with erythro-9-(2-hydroxy-3-nonyl)adenine induces a small increase in PKA activity at the PM and myofilaments in SHAM myocytes; the erythro-9-(2-hydroxy-3-nonyl)adenineinduced response is increased at the PM in HF cells, whereas the erythro-9-(2-hydroxy-3-nonyl)adenine-induced response is reduced at the myofilaments in HF cells (Online Figure III) . Although the PDE2 activity at the SR is minimal in SHAM myocytes, it is increased in HF cells (Online Figure III) .
Together, in healthy rabbit myocytes, the PKA activity at the PM is under predominant control of PDE4, whereas PDE3 hydrolyzes preferentially a pool of cAMP in the vicinity of the myofilaments ( Figure 5 ). In HF rabbit myocytes, the presence of PDE4 activity at the PM is reduced, whereas the activity of PDE3 and PDE2 become more prominent. In contrast, the activity of PDE3 and PDE2 is decreased at the myofilaments ( Figure 5 ; Online Figure III ). These data Figure 6A ). Moreover, PDE4 is shifted to internal compartments, whereas PDE3 is enriched at the sarcolemma region in HF myocytes relative to SHAM controls (Online Figure IV) . The membrane-enriched PDE3
does not colocalize with β 2 AR in HF myocytes (Online Figure IV) . Therefore, in HF myocytes, PDEs may not be effectively coupled to adrenergic receptors. Indeed, although inhibition of PDE4 and PDE3 potentiates adrenergic stimulation-induced PKA phosphorylation of TnI in SHAM myocytes, the effects of these PDE inhibitors are diminished in the HF cells (Online Figure V) . In a separate set of experiments, we applied PKA inhibitors in the FRET measurement to assess the baseline subcellular PKA activity in HF and SHAM myocytes (Online Figure VI) . In SHAM myocytes, we detect a significant reduction of PKA activity by H89 at the myofilaments and the SR but minimal change in PKA activity at the PM (Online Figure VI) . In HF myocytes, the H89-senstive PKA activity at the PM and the SR does not change (Online Figure VI) . However, the H89-senstive PKA activity at the myofilaments is increased in HF cells, indicating an elevation of baseline PKA activity associated with myofilaments in HF myocytes (Online Figure VI) .
Reintroduction of Caveolin-3 Restores Distribution of βAR-Induced PKA Signal, PKA Phosphorylation, and Contractility in Failing Myocytes β 2 AR is enriched in the caveolae of cardiac myocytes, which confines the receptor action to the local PM domains. Disruption of caveolae leads to enhanced β 2 AR stimulation of ion channels at the PM. 16, 21 Previous studies have demonstrated that the expression of caveolin-3 is decreased in different mouse and human cardiac diseases including heart failure and hypertrophy. [22] [23] [24] Loss of caveolin-3 is associated with redistribution of β 2 AR signal on the PM in failing myocytes. 25 Here, we reveal an 80% reduction of protein expression of caveolin-3 in the failing rabbit myocytes. This reduction is associated with an increase of PKA phosphorylation of TnI ( Figure 6A ). Caveolin-3 has a scaffolding domain (C3SD) that is critical for the structure and function of caveolae. A membrane-permeable peptide corresponding to C3SD modulates β 2 AR regulation of L-type calcium channel. 21 We applied the membrane-permeable C3SD peptide to healthy rabbit myocytes to examine whether inhibition of caveolin-3 promotes β 2 AR signal to the myofilaments. Treatment with C3SD significantly enhances β 2 AR-induced PKA activity at the myofilaments but not at the SR (Figure 6B and 6C) . In contrast, a scrambled peptide does not enhance β 2 AR-induced PKA activity at the myofilament. Consistent with the FRET-based measurement of PKA activity, C3SD significantly promotes β 2 AR-induced PKA phosphorylation of TnI at the myofilaments ( Figure 6D ). These data suggest that caveolin-3 plays an essential role in preventing the β 2 AR from signaling to the myofilaments; therefore, loss of caveolin-3 in HF myocytes may permit β 2 AR to signal to the myofilaments to increase PKA activity and substrate phosphorylation.
We sought to restore the expression of caveolin-3 in hypertrophic failing myocytes and to evaluate βAR signaling and PKA activity on the myofilaments. Reintroduction of caveolin-3 partially restores the distribution of PDEs (Online Figure IV ) and their activity in HF myocytes, including an increase in PDE4 activity at the PM and increases in PDE3 and PDE2 activity at the myofilaments (Online Figures III and  VII) . Moreover, reintroduction of caveolin-3 partially normalizes the distribution of β 2 AR (Online Figure VIII) and PKA activity at the subcellular compartments, including increases in PKA activity at the PM and decreases in PKA activity at the SR and myofilaments after stimulation with isoproterenol ( Figure 7A through 7C) . Although the β 1 AR-induced PKA activity is increased at the PM, the β 2 AR-induced PKA activity is decreased throughout the myocytes. Notably, after reintroduction of caveolin-3, the β 2 AR-induced PKA activity does not reach the myofilaments; instead, it is confined to the PM and the SR (Figure 7A through 7C) . Accordingly, the phosphorylation of TnI under β 2 AR stimulation in failing myocytes is significantly diminished after overexpression of caveolin-3 ( Figure 7D ). Finally, overexpression of caveolin-3 restores β-adrenergic-induced contractile shortening response in hypertrophic failing rabbit myocytes ( Figure 7E ).
Discussion
The cardiac PKA activity is fine-tuned to ensure co-ordinated phosphorylation of substrates in different compartments for excitation-contraction coupling at baseline and after adrenergic stimulation. In this study, we have revealed a structuralfunctional remodeling in hypertrophic failing rabbit myocytes that links the redistribution of βAR signal to enhanced PKA phosphorylation of myofilament proteins (Figure 8 ). Although the β 2 AR-induced signal is restricted along the sarcolemma and the SR in healthy myocytes, an augmented β 2 AR signal associated with loss of caveolin-3 is selectively directed to the myofilaments in hypertrophic failing cells. This augmented β 2 AR signal, together with reduced PDE activity associated with myofibrils, promotes strong PKA activity and PKA phosphorylation of the myofilament protein TnI in hypertrophic failing myocytes. Moreover, reintroduction of caveolin-3 is able to normalize the distribution of adrenergic signaling and restores contractile response to adrenergic stimulation in hypertrophic failing rabbit myocytes.
A tonic PKA activity is maintained by adenylyl cyclasedependent cAMP production and PDE-dependent cAMP hydrolysis. 19, 26 Our results show that PDE4 is the major enzyme that controls local PKA activity along the sarcolemma, whereas PDE3 mediates primarily cAMP hydrolysis on the myofilaments ( Figure 5 ). In agreement, both PDE4D and PDE4B display overlap with the membrane marker caveolin-3 (Online Figure II) , consistent with a recent report showing that both enzymes have a binding motif to caveolin-3; 27 loss of caveolin-3 may lead to loss of PDE4 activity at the sarcolemma. In contrast, PDE3 displays a colocalization with myofibrils (Online Figure II) , supporting its primary role in controlling local cAMP and PKA activity there ( Figure 5 ). Meanwhile, we observe a high tonic PKA activity on the myofilaments, which is consistent with a relatively high PKA phosphorylation of myosin-binding protein C and TnI in healthy cardiac tissues. 28 Although the PKA activity is usually depressed in the late stage of human heart failure, 29, 30 there are reports showing preserved or elevated PKA phosphorylation on TnI and PLB. 31,32 It is not completely understood how the cellular PKA activity in myocytes evolves during the course of heart failure development. Here, we observe a redistribution of PKA activity in hypertrophic failing myocytes, including an increased PKA activity at the myofilaments. In agreement, a recent report also shows that PKA phosphorylation of myofilament proteins is elevated in the spontaneous hypertensive rat model. 33 It is therefore possible that PKA activity is redistributed as part of the remodeling of βAR signaling during the compensatory stage before a general depression of PKA activity at the late stage of heart failure. In a classic view, βARs are desensitized in HF due in part to the reduced β 1 AR density at the cell surface, 34 rendering the heart unable to respond to catecholamine stimulation. 6 However, recent progress suggests that βARs can continuously signal at the cell surface 7 and after catecholamine-induced endocytosis. 8 Studies show that βARs are accumulated at the endosome under chronic elevation of sympathetic activity in HF. 35 These βARs may signal from endosomes, offering a potential mechanism on redistribution of PKA activity from the PM to the myofilaments in failing myocytes (Figures 2 and 4) . Further analysis reveals that the diminished β 1 AR signaling contributes to lower PKA activity at the sarcolemma (Figure 4) , which is consistent with previous observations that β 1 AR density is downregulated in this rabbit HF model. 36 In comparison, β 2 AR density is not reduced; 36 rather an augmented β 2 AR signal may be preferentially directed to the myofilaments. Moreover, the shifted PKA activity can be further exacerbated by relocation of PDE3 and PDE2 activity away from the myofilaments to the sarcolemma ( Figure 5 ; Online Figure III) . Together, these observations suggest that the βAR signal undergoes relocation intracellularly during the development of heart failure. Further studies will likely yield novel information on βAR-PKA signal remodeling in subcellular compartments in models of cardiac disease, which may offer insight into cardiac hypertrophic remodeling and compensatory contractility in the heart. Detubulation and loss of caveolae are two prominent features during cardiac structural remodeling; these alterations can in turn promote signal remodeling in cardiac myocytes. Although the β 2 AR is confined in the tubular region in healthy myocytes, chemical disruption of caveolae with a cholesteroldepleting agent, methyl-β-cyclodestrin, results in >60% increase in β 2 AR-dependent PKA phosphorylation of PLB and TnI, as well as lusitropic responses in adult myocytes. 37 In addition, a membrane-permeable peptide representing the C3SD leads to reduction of β 2 AR-dependent PKA phosphorylation of L-type calcium channel at the PM. 21 Detubulation and loss of caveolae in hypertrophic failing myocytes isolated from a mouse model yield broad distribution of β 2 AR signaling along the PM crest. 25, 37 The loss of close proximity of β 2 AR to caveolin-3-associated PDE4 27 can also permit a much broader reach of receptor signaling outside of the T-tubular region in failing cells. 25 In this study, we have observed an amplified β 2 AR signal to the myofilaments after treatment with C3SD to promote PKA phosphorylation of TnI. Together, these observations suggest that inhibition of caveolin-3 leads to a signal shift from the PM to intracellular compartments. Moreover, we observed an amplified β 2 AR signal associated with loss of caveolin-3 in failing rabbit myocytes, which preferentially propagates toward the myofilaments (Figures 2 and 6 ). These data, for the first time, link the redistribution of β 2 AR to amplified PKA signal at the myofilaments in failing myocytes. Furthermore, reintroduction of caveolin-3 in HF myocytes can increase caveolae density, 38 which may facilitate the development and extension of T-tubules 39 and enrichment of β 2 AR to the T-tubule (Online Figure VIII) . Reintroduction of caveolin-3 may also recruit PDE4 enzymes to the proximity of the β 2 AR local domain 27 (Online Figures II and IV) to confine β 2 AR signals in local subcellular environments. 25, 40 Consequently, reintroduction of caveolin-3 effectively prevents β 2 AR from sending a signal to the myofilaments in rabbit failing myocytes and from promoting PKA phosphorylation of TnI (Figure 8 ). Moreover, reintroduction of caveolin-3 could normalize the functional relationship between βAR and the L-type Ca 2+ channel at both T-tubules and caveolae. 16, 21 As a result, the caveolin-3-expressing myocytes become more responsive to adrenergic stimulation to enhance contractility ( Figure 7 ). Together, these data support the notion that caveolin-3 is essential in regulation of compartmented cardiac βAR signaling. In SHAM cardiac myocytes, β1AR has a higher and further reaching response in all 3 subcellular compartments tested than β2AR. β2AR generates a highly localized response within the plasma membrane (PM) and the sarcoplasmic reticulum (SR) but does not induce any significant PKA activity on the myofilaments (MFs). PKA activity at the PM microdomain is under predominant control of PDE4, whereas PDE3 preferentially hydrolyzes a pool of cAMP in the vicinity of MFs. In HF myocytes with reduced caveolin-3, the β adrenergic receptor (βAR)-induced PKA activity at the PM and, to a lesser extent, at the SR is reduced. However, the βAR-induced PKA activity at the myofilament is increased due in part to augmented β2AR signal and miss-localization of PDE3 away from the myofilaments. Reintroduction of caveolin-3 normalizes the distribution of βAR-induced PKA activity at the subcellular compartments, including increases in PKA activity at the PM and decreases in PKA activity at the MFs. In particular, the β2AR-induced PKA activity is confined to the PM and the SR and does not access the myofilaments. PDE indicates phosphodiesterase; PLB, phospholamban; RyR, ryanodine receptor; and SERCA, sarco/ endoplasmic reticulum Ca 2+ -ATPase. by guest on November 18, 2017 http://circres.ahajournals.org/
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Together, this study reveals that structural remodeling leads to βAR signal remodeling in failing myocytes, which yields a decrease in PKA activity at the PM and an increase in β 2 AR-PKA activity and phosphorylation of substrates on the myofilaments in hypertrophic rabbit hearts. Our study suggests caveolin-3 as an essential regulator of subcellular adrenergic signal at the myofilaments in myocytes.
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Online expanded Methods
Development of PKA FRET-based biosensor and adenovirus construction
The regular PKA activity biosensor AKAR3 1 was linked to the C-terminus of cardiac troponin T (provided by Dr. Jianpin Jin, Wayne State University, OH) to generate a myofilament-anchored AKAR3, termed MF-AKAR3. The recombinant construct in pcDNA3.1 (Invitrogen, CA, USA) was verified by DNA sequencing. MF-AKAR3 cDNA was subsequently subcloned into a shuttle vector pAdTrack-CMV to generate recombinant adenovirus according to the manufacturer's instructions (Quantum Biotechnologies, Republic of South Africa). The PM-AKAR3 and SR-AKAR3 have been reported previously.
2, 3
Experimental animals, cardiac myocyte isolation and culture The animal care and experimental protocols followed US National Institutes of Health guidelines and were approved by the Institutional Animal Care and Use Committees of the University of California at Davis. HF was induced in New Zealand White rabbits by combined aortic insufficiency and stenosis as previously described. HF progression was monitored by echocardiography and myocytes were isolated 7.1±1.9 months after aortic constriction when left ventricle end-systolic dimension exceeded 1.4 cm. Briefly, rabbits were sacrificed under general anesthesia (induction with propofol 2 mg/kg followed by 2-5% isoflurane in 100% oxygen). After thoracotomy, the heart was quickly excised and rinsed in cold nominally Ca-free MEM. The right atrium was removed and the aorta opened to visualize the left coronary ostia which was then cannulated using a 4F catheter. 5 Perfusion of the left ventricle and left atrium was established before removal of the right ventricle free wall and application of a purse-string suture to secure the catheter in place. The remainder of the isolation procedure was then essentially as previously described. 6 For myocyte cultures, cells were plated on natural mouse laminin (Life Technologies, Grand Island, NY) coated dishes in culture medium PC-1 (Lonza Walkersville, MD, USA) supplemented with 1% Penicillin-Streptomycin, PH 7.4, filtered) and infected, when specified, with PM-AKAR3, SR-AKAR3, or MF-AKAR3 biosensor together with GFP-caveolin-3 or caveolin-3 for at least 28 hours.
Immunostaining
Confocal microscopy was performed using Zeiss LSM700 microscope (Zeiss, Pleasanton, CA) HF rabbit myocytes expressing flag-β 2 AR alone (lower panels) or together with caveolin-3 (upper panels) are fixed for immunostaining to show distribution of β 2 AR and caveolin-3. 
